Document:

Exhibit
10.9

 

CONSULTANCY
AGREEMENT

 

THIS
CONSULTANCY AGREEMENT is dated July 15, 2020

 

BETWEEN:

 

	(1)	Traxeus
    Pharma Services Limited a company registered in England with a registered office at 85 Great Portland Street, London W1W 7LT (“TRAXEUS”);
    and
	 	 
	(2)	Anebulo
    Pharmaceuticals Inc a company registered in Deleware, USA and having a place of business at 1415 Ranch Road 620 South, Suite 201
    Lakeway, Texas 78734 (“ANEBULO”).

 

	1.	Definition

 

In
this agreement the following terms and phrases shall have the following meaning unless the context otherwise requires:

 

Agreement:
the terms and conditions of this Master Services Agreement and each signed Work Schedule. Each Work Schedule shall be in substantially
similar form to the template that is attached.

 

Confidential
Information: Has the meaning ascribed to it in the confidentiality agreement executed between the parties on March 2, 2020.

 

Deliverables:
deliverables specified in a Statement of Work.

 

Force
Majeure Event: an event or set of circumstances beyond the reasonable control of a Party including without limitation any form of
Government intervention, strikes, lockouts, severe weather, fire, explosion, flood, lightning, act of terrorism, riot, failure of telecommunication
links, war or Act of God.

 

Intellectual
Property Rights: all patents, rights to inventions, utility models, copyright and related rights, trademarks, service marks, trade,
business and domain names, rights in trade dress or get-up, rights in goodwill or to sue for passing off, unfair competition rights,
rights in designs, rights in computer software, database rights, topography rights, moral rights, rights in confidential information
(including know-how and trade secrets) and any other intellectual property rights, in each case whether registered or unregistered and
including all applications for and renewals or extensions of such rights, and all similar or equivalent rights or forms of protection
in any part of the world.

 

Parties:
TRAXEUS and ANEBULO and “Party” means either one of them.

 

Reference
Material: all documents, information and materials provided by or on behalf of ANEBULO to TRAXEUS.

 

Services:
services to be provided by TRAXEUS as specified in a Work Schedule.

 

Work
Schedule: the schedule attached or any subsequent schedule agreed between the parties from time to time and which refers to this
Agreement.

 

TRAXEUS
Methodology: know-how, ideas, concepts, methods and techniques which TRAXEUS alone supplies and which have been generated independently
of any Services or Deliverables together with any improvements thereto that may be developed during the provision of the Services but
which do not rely upon any Confidential Information of ANEBULO.

 

    	1	ANEBULO– Consultancy Agreement

    	 	 	 

    

 

CONSULTANCY
AGREEMENT

 

	2.	Agreement
                                            and Work Schedules

 

	2.1.	This
                                            Agreement will take effect on the date first set out above and will continue in force until
                                            terminated by either party in accordance with clause 11.

 

	2.2.	At
                                            ANEBULO’s request, TRAXEUS will prepare Work Schedules, which with any amendments will
                                            be signed by ANEBULO and TRAXEUS and will form part of this Agreement. Any reference to this
                                            Agreement includes signed Work Schedules.

 

	2.3.	Entering
                                            into this Agreement does not oblige ANEBULO to offer any work to TRAXEUS nor for TRAXEUS
                                            to provide or ANEBULO to accept or pay for any particular services. Neither party wishes
                                            to create or imply any mutuality of obligation between themselves either in the course of
                                            or between any performance of the Services or during any notice period.

 

	2.4.	This
                                            Agreement is not exclusive and ANEBULO acknowledges that TRAXEUS enters into this Agreement
                                            in the course of its business of providing services to its customers. TRAXEUS is and remains
                                            at liberty to also provide services to third parties provided those third parties are not
                                            directly competitive to ANEBULO e.g. another company developing drugs antagonizing the cannabinoid
                                            receptor. ANEBULO is and remains at liberty to engage services (including similar services)
                                            from third parties. TRAXEUS reserves the right to decline to provide any advice and assistance
                                            outside the scope of the Services agreed between the parties, even if TRAXEUS may have provided
                                            such additional advice and assistance before.

 

	3.	TRAXEUS
                                            Responsibilities

 

	3.1.	TRAXEUS
                                            will perform the Services with reasonable skill and care, in a diligent manner and in accordance
                                            with the applicable Work Schedules.

 

	3.2.	TRAXEUS
                                            will endeavour to be responsive to ANEBULO requests and to complete the Services and Deliverables
                                            in line with ANEBULO’s reasonably requested formats and specifications and any laws,
                                            regulations and guidelines specified in the Work Schedules.

 

	3.3.	If
                                            TRAXEUS’s performance of its obligations under this Agreement is prevented or delayed
                                            by any act or omission of ANEBULO or ANEBULO’s agents, subcontractors, consultants
                                            or employees, ANEBULO will bear any and all costs, charges or losses sustained or incurred
                                            as a result.

 

	4.	ANEBULO
                                            Responsibilities

 

	4.1.	ANEBULO
                                            will provide TRAXEUS with copies of Reference Materials TRAXEUS reasonably requires to complete
                                            the Services and Deliverables.

 

	4.2.	Where
                                            ANEBULO’s approval of TRAXEUS’s work or tasks is required before TRAXEUS can
                                            proceed with the next stage of a project or task or in order for TRAXEUS to complete the
                                            Services or Deliverables, ANEBULO will act diligently and in good faith in doing so.

 

	5.	Fees
                                            and Payments

 

	5.1.	ANEBULO
                                            will pay for Services and Deliverables as described in the applicable Statement of Work and
                                            reimburse TRAXEUS for any expenses, such as travel and other expenses, as are reasonable,
                                            necessary, and relate directly to an agreed Deliverable. All expenses in excess of $100 will
                                            be agreed in advance with ANEBULO. Invoices will be issued on completion of a Deliverable
                                            and will include any relevant receipts.

 

	5.2.	ANEBULO
                                            will pay each invoice in full within 30 days of the invoice date and time for payment will
                                            be of the essence of this Agreement.

 

    	2	ANEBULO– Consultancy Agreement

    	 	 	 

    

 

CONSULTANCY
AGREEMENT

 

	5.3.	TRAXEUS
                                            will keep records of time devoted to providing Services and Deliverables. At ANEBULO’s
                                            reasonable request, TRAXEUS will provide copies of documentation to support time and expenses
                                            incurred.

 

	5.4.	If
                                            ANEBULO fails to pay TRAXEUS on the due date for payment, without prejudice to any other
                                            rights and remedies TRAXEUS may have, TRAXEUS may:

 

		(a)	suspend
                                            provision of all or part of the Services and Deliverables under any Statement of Work, until
                                            payment has been made in full; and

		(b)	claim
                                            interest under the Late Payment of Commercial Debts (Interest) Act 1998 and ANEBULO will
                                            pay the interest immediately on demand.

 

	5.5.	If
                                            and when this Agreement or any Statement of Work is terminated, all sums payable to TRAXEUS
                                            for Services and Deliverables completed before that date and which are then outstanding,
                                            become immediately due and ANEBULO will pay them on demand.

 

	6.	Reference
                                            Materials

 

	6.1.	All
                                            Reference Materials will be and remain owned by ANEBULO and TRAXEUS will use all reasonable
                                            efforts to ensure the Reference Materials are not lost or damaged while in its possession
                                            or under its control.

 

	6.2.	If
                                            requested, TRAXEUS will return Reference Materials to ANEBULO upon completion of the Services
                                            and Deliverables or on termination of any Statement of Work or of this Agreement whichever
                                            shall be the earliest.

 

	6.3.	ANEBULO
                                            will indemnify TRAXEUS against any claim and reimburse TRAXEUS up to the amount of this contract
                                            ($100,550) for any loss, liability, expense or cost TRAXEUS must pay as a result of or arising
                                            from any claim by a third party that TRAXEUS’s use of Reference Materials and/or ANEBULO
                                            Confidential Information in accordance with the terms of this Agreement, infringes the rights
                                            including Intellectual Property Rights of a third party.

 

	7.	Deliverables

 

	7.1.	TRAXEUS
                                            shall keep detailed records of the Services provided and shall provide copies of such records
                                            to ANEBULO upon reasonable prior written notice.

 

	7.2.	In
                                            consideration of ANEBULO’s payment for the Services and Deliverables in full and cleared
                                            funds and subject always to clause 8 (TRAXEUS Methodology), TRAXEUS now assigns to ANEBULO
                                            (including by way of a present assignment of future copyright) all Intellectual Property
                                            Rights in and to the Deliverables. TRAXEUS will at ANEBULO’s cost, execute all documents
                                            and do any acts reasonably requested by ANEBULO to give effect to this assignment of Intellectual
                                            Property Rights.

 

	7.3.	Subject
                                            to clause 7.2, all information, documents, data, inventions, discoveries and improvements
                                            deriving from the Deliverables or any compounds which are the subject of a Statement of Work,
                                            will remain and be owned by ANEBULO. TRAXEUS may keep a copy of the Deliverables for legal,
                                            regulatory and audit purposes only.
	 	 
	7.4	TRAXEUS
                                            warrants that to its best knowledge and belief use of the Deliverables by ANEBULO will not
                                            infringe the rights including Intellectual Property Rights of a third party.

 

	8.	TRAXEUS
                                            Methodology

 

	8.1.	All
                                            rights (including Intellectual Property Rights) in and to the TRAXEUS Methodology will remain
                                            and be owned by TRAXEUS.

 

	8.2.	ANEBULO
                                            may use the TRAXEUS Methodology solely to the extent reasonably necessary for ANEBULO to
                                            use, analyse or review the Deliverables, including in making submissions or other disclosures
                                            to government or regulatory authorities. For the avoidance of doubt, no royalty or other
                                            payments are due by ANEBULO in any case.

 

    	3	ANEBULO– Consultancy Agreement

    	 	 	 

    

 

CONSULTANCY
AGREEMENT

 

	9.	Limitation
                                            of Liability

 

	9.1.	This
                                            clause sets out the entire financial liability of TRAXEUS to ANEBULO (including liability
                                            for the acts or omissions of its employees, agents, consultants and subcontractors) in respect
                                            of:

 

(a)
any breach of this Agreement including Work Schedules;

(b)
any use made by ANEBULO of the Deliverables; and

(c)
any representation, statement, act or omission (including negligence) arising out of or in connection with this Agreement.

 

	9.2.	Subject
                                            to clauses 9.3, 9.4, and 9.5, TRAXEUS’s total liability to ANEBULO in contract, tort
                                            (including negligence or breach of statutory duty), misrepresentation, restitution or otherwise
                                            arising in connection with the performance or contemplated performance of this Agreement
                                            (including Work Schedules) will be limited to a sum equivalent to the fees paid by ANEBULO
                                            to TRAXEUS under the applicable Statement of Work.

 

	9.3.	All
                                            warranties, conditions and other terms implied by statute or common law are, to the fullest
                                            extent permitted by law, excluded from this Agreement.

 

	9.4.	TRAXEUS
                                            will not be liable for (i) loss of profits; or (ii) loss of business; or (iii) depletion
                                            of goodwill and/or similar losses; or (iv) loss of anticipated savings; or (v) loss of goods;
                                            or (vi) loss of contract; or (vii) loss of use; or (viii) loss or corruption of data or information;
                                            or (ix) any special, indirect, consequential or pure economic loss, costs, damages, charges
                                            or expenses.

 

	9.5.	Nothing
                                            in this Agreement limits or excludes TRAXEUS’s liability for:

 

		(a)	death
                                            or personal injury resulting from negligence; or

		(b)	any
                                            damage or liability incurred by ANEBULO as a result of TRAXEUS’s fraud or fraudulent
                                            misrepresentation.

	 	(c)	gross negligence

 

	10.	Confidentiality

 

	10.1.	All
                                            Confidential Information will remain the sole and exclusive property of the Party disclosing
                                            it. Each Party agrees to use Confidential Information disclosed to it only for the purposes
                                            of this Agreement.

 

	10.2.	Each
                                            Party undertakes for a period of ten (10) years following the termination of this agreement
                                            to keep secret and treat as confidential and to ensure that its officers, employees and agents
                                            keep secret and treat as confidential, all Confidential Information supplied to it by the
                                            other Party under this Agreement.

 

	10.3.	The
                                            obligations in this Clause 10 will not extend to any information, procedures, systems, documentation
                                            or advice which the receiving Party can demonstrate:

 

		10.3.1.	is
                                            in the public domain or has ceased to be secret (otherwise than as a result of a breach of
                                            this Clause 10);

 

		10.3.2.	is
                                            required to be disclosed by law or by order of a Court of competent jurisdiction;

 

		10.3.3.	is,
                                            at the time of disclosure or use, already in the receiving Party’s possession free
                                            from any obligation of confidentiality or is subsequently acquired from a third party without
                                            obligation of confidentiality; or

 

		10.3.4.	has
                                            been disclosed under a written statement that it is not confidential.

 

    	4	ANEBULO– Consultancy Agreement

    	 	 	 

    

 

CONSULTANCY
AGREEMENT

 

	11.	Termination

 

	11.1.	Either
                                            Party may terminate this Agreement by giving the other Party at least sixty (60) days written
                                            notice.

 

	11.2.	ANEBULO
                                            shall be entitled to terminate any Statement of Work on providing TRAXEUS with at least thirty
                                            (30) days written notice

 

	11.3.	Either
                                            Party may terminate this Agreement by notice in writing to the other Party with immediate
                                            effect if:

 

		11.3.1.	the
                                            other Party commits a material breach of a material provision of this Agreement which is
                                            not capable of remedy or which if capable of remedy, is not remedied within 60 days of the
                                            defaulting Party receiving a written notice from the other Party, specifying the breach and
                                            requiring it to be remedied;

 

		11.3.2.	the
                                            other Party ceases to carry on business, becomes insolvent, has a receiver, administrative
                                            receiver or manager appointed over the whole or any part of its assets, enters into any composition
                                            with creditors generally, has a petition presented for the making of an administration order
                                            or has an order made or resolution passed for it to be wound up (otherwise than in furtherance
                                            of any scheme for amalgamation or reconstruction) or undergoes any similar or equivalent
                                            process in any jurisdiction; or

 

	11.4.	On
                                            termination of this Agreement or any Statement of Work ANEBULO will pay TRAXEUS those fees
                                            and expenses due for Services and Deliverables provided or irrevocably committed to before
                                            the date of termination in accordance with clause 5.4.

 

	12.	Events
                                            beyond our control

 

	12.1.	If
                                            either ANEBULO or TRAXEUS is prevented or hindered from carrying out any of its obligations
                                            under a Statement of Work by a Force Majeure Event then the performance of its obligations
                                            will be suspended for the duration of the Force Majeure Event and the Party affected will
                                            not be liable for any delay in the performance of its obligations, provided that if the Force
                                            Majeure Event lasts for more than 6 months, either Party may terminate the relevant Statement
                                            of Work by giving the other Party one month’s notice in writing.

 

	12.2.	If
                                            a Statement of Work is suspended or terminated under Clause 12.1, TRAXEUS will provide ANEBULO
                                            with a report of the Services and Deliverables completed under the Statement of Work before
                                            its suspension or termination, and ANEBULO will pay TRAXEUS the fees and expenses for the
                                            Services and Deliverables completed.

 

	13.	Entire
                                            Agreement

 

	13.1.	This
                                            Agreement is the entire agreement and understanding between ANEBULO and TRAXEUS concerning
                                            the subject matter of the Agreement and supersedes any and all other agreements or statements
                                            between ANEBULO and TRAXEUS. [For the avoidance of doubt disclosures made under the Confidentiality
                                            Agreement between the Parties of 02 March 2020 shall be governed by that agreement up to
                                            the date of execution of this Agreement and by the terms of this Agreement from that date
                                            forward]

 

	13.2.	Amendments
                                            to this Agreement (including Work Schedules) must be in writing and signed by authorised
                                            representatives of each Party.

 

	14.	Law
                                            and disputes

 

This
Agreement and any rights arising out of this Agreement will be governed by the Laws of England. Before either Party starts any court
proceedings in respect of a dispute, each agrees to discuss the matter in good faith with the other Party with a view to resolving it.
If the dispute is not resolved following good faith discussions between the Parties, and if so requested by either party with the assistance
of a mediator, the dispute will be referred to and dealt with as follows: if ANEBULO sues TRAXEUS, it will be in an English court and
if TRAXEUS sues Anebulo it will be in a Texas, USA court.

 

    	5	ANEBULO– Consultancy Agreement

    	 	 	 

    

 

CONSULTANCY
AGREEMENT

 

	15.	Notices

 

	15.1.	Any
                                            notice required to be given under this Agreement will be sufficiently given if sent to the
                                            address of the Party first written above by prepaid recorded delivery, registered post, fax
                                            or email and such notices will be deemed to have been received by the addressee 10 days after
                                            posting (if sent by post), on printed confirmation of successful transmission (if sent by
                                            fax) or one hour after transmission ( if sent by email).

 

	16.	Other
                                            terms

 

	16.1.	Clauses
                                            5, 6, 7, 8, 9, 10, 11.4, 12.2, 14, 15 and 16 will survive termination of this Agreement.

 

	16.2.	Either
                                            Party’s failure to exercise or enforce any right conferred upon it by this Agreement
                                            will not be deemed to be a waiver of such right or prevent the exercise or enforcement of
                                            that right in the future.

 

	16.3.	Nothing
                                            in this Agreement and no action taken by the Parties under this Agreement will constitute
                                            or be deemed to constitute a partnership between the Parties, or will constitute either Party
                                            as the agent, employee or representative of the other.

 

	16.4.	TRAXEUS
                                            shall be entitled to engage subcontractors to carry out any part of the Services but shall
                                            advise ANEBULO of the identity of any proposed subcontractor in advance and ANEBULO shall
                                            be entitled on reasonable and objective grounds to require that TRAXEUS use an alternative
                                            subcontractor.

 

	16.5.	Neither
                                            party shall use the name of the other in any marketing or publicity without the prior written
                                            consent of the other.

 

By
signing below the Parties agree to the terms and conditions of this Agreement as set out on this and the preceding five pages and in
the Schedule hereto.

 

	Authorised
    signatory for and on behalf of:	 	Authorised
    signatory for and on behalf of:
	 	 	 
	Traxeus
    Pharma Services Limited:	 	Anebulo
    Pharmaceuticals Inc:
	 	 	 
	/s/
    Margaret Courtney	 	/s/
    Joseph F. Lawler

 

	Name:	Margaret
    Courtney	 	Name:	Joseph
    F. Lawler
	 	 	 	 	 
	Position:	Director	 	Position:	President
	 	 	 	 	 
	Date:	15
    July 2020	 	Date:	15
    July 2020

 

    	6	ANEBULO– Consultancy Agreement

    	 	 	 

    

 

CONSULTANCY
AGREEMENT

 

Statement
of Work

 

This
Statement of Work is governed by the terms and conditions of the Master Services Agreement between TRAXEUS and ANEBULO dated 15 July
2020 (“Agreement”). Capitalised words used in this Statement of Work have the meanings given to them in the Agreement.

 

Description
of Services / Deliverables:

 

TRAXEUS
will provide pharmaceutical development services to ANEBULO in relation to the retest of an existing batch of drug substance and to manage
the manufacture of clinical supplies.

 

	Deliverable	 	Fees (USD)	 
	Drug Substance	 	 	 	 
	Selection of CMO	 	 	3400	 
	Approved Scope of Work and Master Services
    Agreement	 	 	3400	 
	Complete the transfer and development of analytical
    test methods at CMO.	 	 	3550	 
	Complete the validation of analytical test
    methods	 	 	4570	 
	Qualification of analytical reference standard	 	 	2265	 
	cGMP retest of existing drug substance batch	 	 	2265	 
	Complete process familiarisation	 	 	4920	 
	Manufacture and testing of demonstration batch	 	 	4920	 
	Review and approval of cGMP documents including
    master batch records and specification	 	 	4070	 
	Manufacture and release of cGMP batch	 	 	9510	 
	Approve campaign report and initiate cGMP stability
    study	 	 	1360	 
	Approve annual stability reports (12 and 24
    months)	 	 	560	 
	Drug Product
	Selection of CMO	 	 	6280	 
	Approved Scope of Work and Master Services
    Agreement	 	 	4680	 
	Complete the transfer and development of analytical
    test methods at CMO.	 	 	4790	 
	Complete the validation of analytical test
    methods	 	 	3905	 
	Complete formulation development	 	 	3780	 
	Complete process development	 	 	4920	 
	Review and approval of cGMP documents including
    master batch records and specification	 	 	3075	 
	Manufacture and release of cGMP batch and initiate
    cGMP stability study	 	 	6175	 
	Approve annual stability reports (12 and 24
    month)	 	 	1150	 
	Packaging & Labelling CMO Selection &
    Set-up & cGMP batch	 	 	3400	 

 

    	7	ANEBULO– Consultancy Agreement

    	 	 	 

    

 

CONSULTANCY AGREEMENT

 

	Regulatory
    and Quality
	Complete the update of the drug
    substance section of the IMPD	 	 	5670	 
	Complete the update of the drug product section
    of the IMPD	 	 	5040	 
	Issue expiry update information (Estimate 1
    updates)	 	 	630	 
	Issue all required CMC SOPs	 	 	2265	 

 

Proposed
Project Timelines:

 

To
begin in July 2020

 

Payment
schedule:

 

Invoices
shall be submitted to on completion of a deliverable.

Payment
will be 30 days from receipt of invoice.

 

Expenses
incurred in relation to a deliverable will included in the invoice.

For
guidance the expenses related to travel to the contract manufacturers are expected to be between $3,000 and $5,000 assuming all organisations
are based in UK or EU.

 

Accepted
and agreed

 

	Authorised
    signatory for and on behalf of:	 	Authorised
    signatory for and on behalf of:
	 	 	 
	Traxeus
    Pharma Services Limited:	 	Anebulo
    Pharmaceuticals Inc:
	 	 	 
	/s/
    Margaret Courtney	 	/s/
    Joseph F. Lawler

 

	Name:	Margaret
    Courtney	 	Name:	Joseph
    F. Lawler
	Position:	Director	 	Position:	President
    
	Date:	15
    July 2020	 	Date:	15
    July 2020 

 

    	8	ANEBULO– Consultancy AgreementExhibit 10.1

 

AT
HOME GROUP INC. 2016 Equity Incentive Plan

FORM OF PERFORMANCE SHARE UNIT - Notice of Grant

 

At
Home Group Inc. (the “Company”), a Delaware corporation, hereby grants to the Grantee set forth below (the “Grantee”)
Performance Share Units (the “Performance Share Units”), pursuant to the terms and conditions of this Notice of Grant
(the “Notice”), the Performance Share Unit Award Agreement (reference number 20[__]-[__]1) attached
hereto as Exhibit A (the “Award Agreement”), and the Amended and Restated At Home Group Inc. 2016 Equity Incentive
Plan (as amended from time to time, the “Plan”). Capitalized terms used but not defined herein shall have the meaning
attributed to such terms in the Award Agreement or, if not defined therein, in the Plan, unless the context requires otherwise. Each
Performance Share Unit represents the right to receive one (1) Share at the time and in the manner set forth in Section 4 of the Award
Agreement.

 

Date of Grant:[●]

 

Name of Grantee:[●]

 

Target Number of 

Performance Share Units:[●]

 

Maximum Number of 

Performance Share Units:[●]

 

Vesting:
The Performance Share Units shall vest pursuant to the terms and conditions set forth in Section 3 of the Award Agreement.

 

The Performance Share Units shall be subject to
the execution and return of this Notice by the Grantee to the Company within 30 days of the date hereof (including by utilizing an electronic
signature and/or web-based approval and notice process or any other process as may be authorized by the Company). By executing this Notice,
the Grantee acknowledges that his or her agreement to the covenants set forth in Section 6 of the Award Agreement is a material inducement
to the Company in granting this Award to the Grantee.

 

This Notice may be executed by facsimile or electronic
means (including, without limitation, PDF) and in one or more counterparts, each of which shall be considered an original instrument,
but all of which together shall constitute one and the same agreement, and shall become binding when one or more counterparts have been
signed by each of the parties hereto and delivered to the other party hereto.

 

[Signature Page Follows]

 

 

 

1 To be updated
as necessary to be consistent with the referenced award agreement to which the notice relates.

 

     

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed this Notice of Grant as of the Date of Grant set forth above.

 

 

	 	AT HOME GROUP INC.
	 	 	 
	 	By:	 
	 	Name:	[●]
	 	Title:	[●]

 

	 	GRANTEE
	 	 	 
	 	By:	 
	 	Name:	[●]

 

[Signature Page to Notice of Performance Share Unit Grant for At Home Group Inc. 2016 Equity Incentive Plan]

 

     

     

    

 

Exhibit
A

AT HOME GROUP INC.

2016 EQUITY INCENTIVE PLAN

PERFORMANCE SHARE UNIT

Award Agreement

Reference Number: 20[__][__]2

 

THIS PERFORMANCE SHARE UNIT AWARD AGREEMENT (the
“Award Agreement”) is entered into by and among At Home Group Inc. (the “Company”), a Delaware corporation,
and the individual set forth on the signature page to that certain Notice of Grant (the “Notice”) to which this Award
Agreement is attached. The terms and conditions of the Performance Share Units granted hereby, to the extent not controlled by the terms
and conditions contained in the Plan, shall be as set forth in the Notice and this Award Agreement. Capitalized terms used but not defined
herein shall have the meaning attributed to such terms in the Notice or, if not defined therein, in the Plan, unless the context requires
otherwise. References herein to the Award Agreement shall also be deemed to refer to the Notice as the context requires or is otherwise
appropriate.

 

1.                 
No Right to Continued Employee Status or Consultant Service 

 

Nothing contained in this Award Agreement shall
confer upon the Grantee the right to the continuation of his or her Employee status, or, in the case of a Consultant or Director, to the
continuation of his or her service arrangement, or in either case to interfere with the right of the Company or any of its Subsidiaries
or other Affiliates to Terminate the Grantee.

 

2.                 
Term of Performance Share Units 

 

This Award Agreement shall remain in effect until
the Performance Share Units have fully vested and been settled or been forfeited by the Grantee as provided in this Award Agreement.

 

3.                 
Vesting of Performance Share Units.

 

(a)              
Subject to the remainder of this Section 3, Performance Share Units (up to the Maximum Number of Performance Share Units) shall
vest if and to the extent the performance goals set forth in Exhibit A attached hereto (the “Performance Goals”)
are achieved as of the determination date set forth in Exhibit A (the “Performance Determination Date”), subject
to the Grantee’s not having Terminated prior to the Performance Determination Date.

 

 

 

2 To be updated as
appropriate.

 

    1

     

    

 

If the Grantee Terminates for any reason, the
portion of the Performance Share Units that has not vested as of such date shall terminate upon such Termination and be deemed to have
been forfeited by the Grantee without consideration. [Notwithstanding the foregoing, if the Grantee’s Termination is due to Qualifying
Retirement, then the Performance Share Units shall not terminate as a result of such Qualifying Retirement and shall remain eligible
to vest in accordance with this Section 3(a) as if the Grantee had not experienced a Termination; provided that the number of
Performance Share Units (if any) that vest in accordance with this Section 3(a) following such Qualifying Retirement shall equal the
product of (i) the number of Performance Share Units that would have vested in accordance with this Section 3(a) but for the Qualifying
Retirement multiplied by (ii) the Retirement Factor.]3

 

(b)              
Notwithstanding anything to the contrary in Section 3(a), (i) if a Change in Control is consummated prior to the Grantee’s
Termination, achievement of the Performance Goals shall be determined by the Board in its good faith discretion as of the date on which
such Change in Control is consummated and the portion of the Performance Share Units that would have vested pursuant to Exhibit A
based on such level of achievement or, if greater, the Target Number of Performance Share Units (such greater amount, the “CIC
Performance Share Units”) shall remain issued, outstanding, and eligible to vest and shall fully vest (100%) upon the Performance
Determination Date, subject to the Grantee’s not having Terminated prior to the Performance Determination Date; provided,
that, (x) the CIC Performance Share Units, to the extent then issued and outstanding, shall become fully (100%) vested upon the
Grantee’s Termination by the Company without Cause or by the Grantee’s resignation for Good Reason, in either case, on or
within one year following the consummation of a Change in Control, [and (y) upon a Qualifying Retirement (other than for Good Reason),
a pro rata portion of the CIC Performance Share Units based on the Retirement Factor shall vest and the remaining portion of the CIC
Performance Share Units shall automatically be forfeited without consideration, and (ii) if a Change in Control is consummated following
a Qualifying Retirement, a prorated portion of the CIC Performance Share Units will vest upon such Change in Control based on the Retirement
Factor.]4 For the avoidance of doubt, any
portion of the Performance Share Units other than the CIC Performance Share Units (if any) (or pro rata portion thereof, as applicable)
shall be deemed to have been forfeited by the Grantee without consideration effective as of the date on which the Change in Control is
consummated.

 

(c)              
Definitions. For purposes of this Award Agreement, the following terms shall have the below meanings:

 

(i)                
“Good Reason” shall mean (a) if the Grantee is party to an employment or a severance agreement with the Company
or one of the Subsidiaries in which “Good Reason” is defined, the occurrence of any circumstances defined as “Good Reason”
in such employment or severance agreement, or (b) if the Grantee is not party to an employment or severance agreement with the Company
or one of the Subsidiaries in which “Good Reason” is defined, (i) a material reduction in the Grantee’s annual base
salary or compensation (including target annual bonus opportunity), or (ii) any material and adverse change in the Grantee’s position,
title or status or any change in the Grantee’s job duties, authority or responsibilities to those of lesser status. A termination
of employment by the Grantee for Good Reason shall be effectuated by giving the Company written notice of the termination, setting forth
the conduct of the Company that constitutes Good Reason, within thirty (30) days of the first date on which the Grantee has knowledge
of such conduct. The Grantee shall further provide the Company at least thirty (30) days following the date on which such notice is provided
to cure such conduct. Failing such cure, a termination of employment by the Grantee for Good Reason shall be effective on the day following
the expiration of such cure period.

 

 

 

3 Not
applicable to Awards to Chief Executive Officer.

4 Not applicable
to Awards to Chief Executive Officer.

 

    2

     

    

 

(ii)             
[“Qualifying Retirement” means a Retirement that occurs at least six months following the Date of Grant and
within twelve (12) months prior to the Performance Determination Date.

 

(iii)           
“Retirement” means the Grantee’s Termination by voluntary resignation for any reason after attaining a
combination of fifty-five (55) years of age with at least ten (10) years of service; provided, that a Termination shall
not constitute a Retirement if grounds for Cause existed at the time of such Termination.

 

(iv)            
“Retirement Factor” means a fraction, the numerator of which is the number of calendar days in the Performance
Cycle set forth in Exhibit A prior to a Qualifying Retirement and the denominator of which is the number of calendar days in the
Performance Cycle.]5

 

4.                 
Settlement

 

Vested
Performance Share Units will be settled within thirty (30) days following the Performance Determination Date, through the Company’s
delivery to the Grantee of one (1) Share in settlement of each vested Performance Share Unit; provided, however, that vested
Performance Share Units will be settled within thirty (30) days following a Termination without Cause, resignation for Good Reason[,
or Qualifying Retirement]6, in each case, that occurs within one year following a Change in Control.

 

5.                 
Termination of Service 

 

If the Grantee incurs a Termination for any reason,
whether voluntarily or involuntarily, then the portion of the Performance Share Units that have not previously vested (after taking into
account any vesting in connection with such Termination pursuant to Section 3) shall terminate as of the date of the Grantee’s Termination.
If the Grantee incurs a Termination for Cause, then the Performance Share Units (whether or not vested) shall be forfeited and terminate
immediately without consideration upon the effective date of such Termination for Cause.

 

6.                 
Prohibited Activities 

 

(a)              
No Sale or Transfer. Unless otherwise required by law, the Performance Share Units shall not be (i) sold, transferred or
otherwise disposed of, (ii) pledged or otherwise hypothecated or (iii) subject to attachment, execution or levy of any kind, other than
by will or by the laws of descent or distribution; provided, however, that any transferred Performance Share Units will
be subject to all of the same terms and conditions as provided in the Plan and this Award Agreement and the Grantee’s estate or
beneficiary appointed in accordance with the Plan will remain liable for any withholding tax that may be imposed by any federal, state
or local tax authority.

 

 

 

5 Not applicable
to Awards to Chief Executive Officer.

6 Not applicable
to Awards to Chief Executive Officer.

 

    3

     

    

 

(b)              
Right to Terminate Performance Share Units and Recovery. The Grantee understands and agrees that the Company has granted
the Performance Share Units to the Grantee to reward the Grantee for the Grantee’s future efforts and loyalty to the Company and
its

 

Affiliates by giving the Grantee the opportunity
to participate in the potential future appreciation of the Company. Accordingly, if (a) the Grantee materially violates the Grantee’s
obligations relating to the non-disclosure or non-use of confidential or proprietary information under any Restrictive Agreement to which
the Grantee is a party, or (b) the Grantee materially breaches or violates the Grantee’s obligations relating to non-disparagement
under any Restrictive Agreement to which the Grantee is a party, or (c) the Grantee engages in any activity prohibited by Section 6 of
this Award Agreement, or (d) the Grantee materially breaches or violates any non-solicitation obligations under any Restrictive Agreement
to which the Grantee is a party, or (e) the Grantee breaches or violates any non-competition obligations under any Restrictive Agreement
to which the Grantee is a party, or (f) the Grantee is convicted of a felony against the Company or any of its Affiliates, then, in addition
to any other rights and remedies available to the Company, the Company shall be entitled, at its option, exercisable by written notice,
to terminate the Performance Share Units (including the vested portion of the Performance Share Units) without consideration, which shall
be of no further force and effect. “Restrictive Agreement” shall mean any agreement between the Company or any Subsidiary
and the Grantee that contains non-competition, non-solicitation, non-hire, non-disparagement, or confidentiality restrictions applicable
to the Grantee.

 

(c)              
Other Remedies. The Grantee specifically acknowledges and agrees that its remedies under this Section 6 shall not prevent
the Company or any Subsidiary from seeking injunctive or other equitable relief in connection with the Grantee’s breach of any Restrictive
Agreement. In the event that the provisions of this Section 6 should ever be deemed to exceed the limitation provided by applicable law,
then the Grantee and the Company agree that such provisions shall be reformed to set forth the maximum limitations permitted.

 

7.                 
No Rights as Stockholder 

 

The Grantee shall have no rights as a stockholder
with respect to the Shares covered by the Performance Share Units until the effective date of issuance of the Shares and the entry of
the Grantee’s name as a shareholder of record on the books of the Company following delivery of the Shares in settlement of the
Performance Share Units.

 

8.                 
Taxation Upon Settlement of the Performance Share Units; Tax Withholding; Parachute Tax Provisions

 

The Grantee understands that the Grantee will
recognize income, for Federal, state and local income tax purposes, as applicable, in respect of the vesting and/or settlement of the
Performance Share Units. The acceptance of the Shares by the Grantee shall constitute an agreement by the Grantee to report such income
in accordance with then applicable law and to cooperate with Company and its subsidiaries in establishing the amount of such income and
corresponding deduction to the Company and/or its subsidiaries for its income tax purposes.

 

    4

     

    

 

The Grantee is responsible for all tax obligations
that arise as a result of the vesting and settlement of the Performance Share Units. The Company may withhold from any amount payable
to the Grantee an amount sufficient to cover any Federal, state or local withholding taxes which may become required with respect to such
vesting and settlement or take any other action it deems necessary to satisfy any income or other tax withholding requirements as a result
of the vesting and settlement of the Performance Share Units. The Company shall have the right to require the payment of any such taxes
and require that the Grantee, or the Grantee’s beneficiary, to furnish information deemed necessary by the Company to meet any tax
reporting obligation as a condition to delivery of any Shares pursuant to settlement of the Performance Share Units. The Grantee may pay
his or her withholding tax obligation in connection with the vesting and settlement of the Performance Share Units, by making a cash payment
to the Company. In addition, the Committee, in its sole discretion, may allow the Grantee, to pay his or her withholding tax obligation
in connection with the vesting and settlement of the Performance Share Units, by (x) having withheld a portion of the Shares then issuable
to him or her upon settlement of the Performance Share Units or (z) surrendering Shares that have been held by the Grantee for at least
six (6) months (or such lesser period as may be permitted by the Committee) prior to the settlement of the Performance Share Units, in
each case having an aggregate Fair Market Value equal to the withholding taxes.

 

In connection with the grant of the Performance
Share Units, the parties wish to memorialize their agreement regarding the treatment of any potential golden parachute payments as set
forth in Exhibit B attached hereto.

 

9.                 
Securities Laws 

 

(a)              
Upon the acquisition of any Shares pursuant to the settlement of the Performance Share Units, the Grantee will make such written
representations, warranties, and agreements as the Committee may reasonably request in order to comply with securities laws or with this
Award Agreement. Grantee hereby agrees not to offer, sell or otherwise attempt to dispose of any Shares issued to the Grantee upon settlement
of the Performance Share Units in any way which would: (x) require the Company to file any registration statement with the Securities
and Exchange Commission (or any similar filing under state law or the laws of any other county) or to amend or supplement any such filing
or (y) violate or cause the Company to violate the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended,
the rules and regulations promulgated thereunder, or any other Federal, state or local law, or the laws of any other country. The Company
reserves the right to place restrictions on any Shares the Grantee may receive as a result of the settlement of the Performance Share
Units.

 

(b)              
Notwithstanding anything to the contrary herein, in the event that (i) the Grantee is subject to the Company’s insider trading
policy, including any policy permitting officers and directors to sell Shares only during certain “window” periods, in effect
from time to time (collectively, the “Policy”) or the Grantee is otherwise prohibited from selling Shares in the public
market and any Shares underlying the Grantee’s Performance Share Units are scheduled to be delivered on a settlement date (the “Original
Settlement Date”) that (A) does not occur during an open “window period” applicable to the Grantee or on a day on
which the Grantee is permitted to sell Shares underlying any portion of the Performance Share Units that has vested pursuant to a written
plan that meets the requirements of Rule 10b5-1 under the Exchange Act, as determined by the Company in accordance with the Policy, as
applicable, or (B) does not occur on a date when the Grantee is otherwise permitted to sell Shares on the open market, and (ii) the Company
elects not to satisfy the Grantee’s tax withholding obligations by withholding Shares from the Grantee’s distribution, then
such Shares shall not be delivered on such Original Distribution Date and shall instead be delivered, as applicable, on (x) the first
business day of the next occurring open “window period” applicable to the Grantee pursuant to the Policy, or (y) the next
business day on which the Grantee is not otherwise prohibited from selling Shares in the open market, but in no event later than March
15th of year following the year in which the Performance Share Units vest.

 

    5

     

    

 

10.             
Modification, Amendment, and Termination of Performance Share Units 

 

This Award Agreement may not be modified, amended,
terminated and no provision hereof may be waived in whole or in part except by a written agreement signed by the Company and the Grantee
and no modification shall, without the consent of the Grantee, alter to the Grantee’s material detriment or materially impair any
rights of the Grantee under this Award Agreement except to the extent permitted under the Plan.

 

11.             
Notices 

 

Unless otherwise provided herein, any notices
or other communication given or made pursuant to the Notice, this Award Agreement or the Plan shall be in writing and shall be deemed
to have been duly given (i) as of the date delivered, if personally delivered (including receipted courier service) or overnight delivery
service, with confirmation of receipt; (ii) on the date the delivering party receives confirmation, if delivered by facsimile to the number
indicated or by email to the address indicated or through an electronic administrative system designated by the Company; (iii) one (1)
business day after being sent by reputable commercial overnight delivery service courier, with confirmation of receipt; or (iv) three
(3) business days after being mailed by registered or certified mail, return receipt requested, postage prepaid and addressed to the intended
recipient as set forth below:

 

(a)              
If to the Company at the address below:

 

At Home Group Inc.

1600 East Plano Parkway

Plano, Texas 75074

Attn: General Counsel

Phone: (972) 265-6227

 

(b)              
If to the Grantee, at the most recent address, facsimile number or email contained in the Company’s records.

 

    6

     

    

 

12.             
Award Agreement Subject to Plan and Applicable Law 

 

This Award Agreement is made pursuant to the Plan
and shall be interpreted to comply therewith. A copy of the Plan is attached hereto. Any provision of this Award Agreement inconsistent
with the Plan shall be considered void and replaced with the applicable provision of the Plan. The Plan shall control in the event there
shall be any conflict between the Plan, the Notice, and this Award Agreement, and it shall control as to any matters not contained in
this Award Agreement. The Committee shall have authority to make constructions of this Award Agreement, and to correct any defect or supply
any omission or reconcile any inconsistency in this Award Agreement, and to prescribe rules and regulations relating to the administration
of this Award and other Awards granted under the Plan.

 

This Award Agreement shall be governed by the
laws of the State of Delaware, without regard to the conflicts of law principles thereof, and subject to the exclusive jurisdiction of
the courts therein. The Grantee hereby consents to personal jurisdiction in any action brought in any court, federal or state, within
the State of Delaware having subject matter jurisdiction in the matter.

 

13.             
Section 409A

 

The Performance Share Units are intended to comply
with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and, accordingly, to the maximum extent
permitted, this Award Agreement shall be interpreted to be in compliance therewith. Nothing contained herein shall constitute any representation
or warranty by the Company regarding compliance with Section 409A of the Code. The Company shall have no obligation to take any action
to prevent the assessment of any additional income tax, interest or penalties under Section 409A of the Code on any Person and the Company,
its Subsidiaries and Affiliates, and each of their respective employees and representatives, shall have no liability to the Grantee with
respect thereto. Notwithstanding anything in this Award Agreement to the contrary, if the Grantee is a “specified employee”
for purposes of Section 409A of the Code at the time of his or her Termination, any Performance Share Units settleable upon or in connection
with the Grantee’s Termination shall be delayed and will be made on the day after the first to occur of (a) the day which is six
(6) months following the date of such Termination, and (b) the date of the Grantee’s death. For purposes of the settlement of any
amounts deemed to be “nonqualified deferred compensation” under Section 409A of the Code upon a Termination, the terms “Terminate”,
“Terminated”, and “Termination” shall mean a Termination of the Grantee that constitutes a “separation from
service” within the meaning of Section 409A of the Code. For purposes of Section 409A of the Code, the right to a series of installment
payments under this Award Agreement shall be treated as a right to a series of separate payments.

 

14.             
Headings and Capitalized Terms 

 

Unless otherwise provided herein, capitalized
terms used herein that are defined in the Plan and not defined herein shall have the meanings set forth in the Plan. Headings are for
convenience only and are not deemed to be part of this Award Agreement. Unless otherwise indicated, any reference to a Section herein
is a reference to a Section of this Award Agreement.

 

    7

     

    

 

15.             
Severability and Reformation 

 

If any provision of this Award Agreement shall
be determined by a court of law of competent jurisdiction to be unenforceable for any reason, such unenforceability shall not affect the
enforceability of any of the remaining provisions hereof; and this Award Agreement, to the fullest extent lawful, shall be reformed and
construed as if such unenforceable provision, or part thereof, had never been contained herein, and such provision or part thereof shall
be reformed or construed so that it would be enforceable to the maximum extent legally possible.

 

16.             
Binding Effect 

 

This Award Agreement shall be binding upon the
parties hereto, together with their personal executors, administrator, successors, personal representatives, heirs and permitted assigns.

 

17.             
Entire Agreement 

 

This Award Agreement, together with the Plan,
supersedes all prior written and oral agreements and understandings among the parties as to its subject matter and constitutes the entire
agreement of the parties with respect to the subject matter hereof. If there is any conflict between the Notice, this Award Agreement
and the Plan, then the applicable terms of the Plan shall govern.

 

18.             
Waiver 

 

Waiver by any party of any breach of this Award
Agreement or failure to exercise any right hereunder shall not be deemed to be a waiver of any other breach or right whether or not of
the same or a similar nature. The failure of any party to take action by reason of such breach or to exercise any such right shall not
deprive the party of the right to take action at any time while or after such breach or condition giving rise to such rights continues.

 

    8

     

    

 

Exhibit
A

PERFORMANCE GOALS AND PERFORMANCE CYCLE

 

    A-1

     

    

 

Exhibit
B

PARACHUTE TAX PROVISIONS

 

This Exhibit B sets forth the terms and
provisions applicable to the Grantee pursuant to the provisions of Section 8 of the Award Agreement. This Exhibit B shall be subject
in all respects to the terms and conditions of the Award Agreement.

 

(a)              
To the extent that the Grantee, would otherwise be eligible to receive a payment or benefit pursuant to the terms of this Award
Agreement, any employment or other agreement with the Company or any Subsidiary or otherwise in connection with, or arising out of, the
Grantee’s employment with the Company or a change in ownership or effective control of the Company or of a substantial portion of
its assets (any such payment or benefit, a “Parachute Payment”), that a nationally recognized United States public
accounting firm selected by the Company (the “Accountants”) determines, but for this sentence would be subject to excise
tax imposed by Section 4999 of the Code (the “Excise Tax”), subject to clause (c) below, then the Company shall pay
to the Grantee whichever of the following two alternative forms of payment would result in the Grantee’s receipt, on an after-tax
basis, of the greater amount of the Parachute Payment notwithstanding that all or some portion of the Parachute Payment may be subject
to the Excise Tax: (1) payment in full of the entire amount of the Parachute Payment (a “Full Payment”), or (2) payment
of only a part of the Parachute Payment so that the Grantee receives the largest payment possible without the imposition of the Excise
Tax (a “Reduced Payment”).

 

(b)              
If a reduction in the Parachute Payment is necessary pursuant to clause (a), then the reduction shall occur in the following order:
(1) cancellation of acceleration of vesting on any equity awards for which the exercise price exceeds the then fair market value of the
underlying equity; (2) reduction of cash payments (with such reduction being applied to the payments in the reverse order in which they
would otherwise be made, that is, later payments shall be reduced before earlier payments); and (3) cancellation of acceleration of vesting
of equity awards not covered under (1) above; provided, however, that in the event that acceleration of vesting of equity
awards is to be cancelled, acceleration of vesting of full value awards shall be cancelled before acceleration of options and stock appreciation
rights and within each class such acceleration of vesting shall be cancelled in the reverse order of the date of grant of such equity
awards, that is, later equity awards shall be canceled before earlier equity awards; and provided, further, that to the
extent permitted by Code Section 409A and Sections 280G and 4999 of the Code, if a different reduction procedure would be permitted without
violating Code Section 409A or losing the benefit of the reduction under Sections 280G and 4999 of the Code, the Grantee may designate
a different order of reduction.

 

(c)              
For purposes of determining whether any of the Parachute Payments (collectively the “Total Payments”) will be
subject to the Excise Tax and the amount of such Excise Tax, (i) the Total Payments shall be treated as “parachute payments”
within the meaning of Section 280G(b)(2) of the Code, and all “parachute payments” in excess of the “base amount”
(as defined under Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless and except to the extent that,
in the opinion of the Accountants, such Total Payments (in whole or in part): (1) do not constitute “parachute payments,”
including giving effect to the recalculation of stock options in accordance with Treasury Regulation Section 1.280G-1, Q&A 33, (2)
represent reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code in excess of the
“base amount” or (3) are otherwise not subject to the Excise Tax, and (ii) the value of any non-cash benefits or any deferred
payment or benefit shall be determined by the Accountants in accordance with the principles of Section 280G of the Code.

 

    B-1

     

    

 

(d)              
All determinations hereunder shall be made by the Accountants, which determinations shall be final and binding upon the Company
and the Grantee.

 

(e)              
The federal tax returns filed by the Grantee (and any filing made by a consolidated tax group which includes the Company) shall
be prepared and filed on a basis consistent with the determination of the Accountants with respect to the Excise Tax payable by the Grantee.
The Grantee shall make proper payment of the amount of any Excise Tax, and at the request of the Company, provide to the Company true
and correct copies (with any amendments) of his or her federal income tax return as filed with the Internal Revenue Service, and such
other documents reasonably requested by the Company, evidencing such payment (provided that the Grantee may delete information
unrelated to the Parachute Payment or Excise Tax and provided, further that the Company at all times shall treat such returns
as confidential and use such return only for purpose contemplated by this paragraph).

 

(f)               
In the event of any controversy with the Internal Revenue Service (or other taxing authority) with regard to the Excise Tax, the
Grantee shall permit the Company to control issues related to the Excise Tax (at its expense), provided that such issues do not potentially
materially adversely affect the Grantee but the Grantee shall control any other issues. In the event that the issues are interrelated,
the Grantee and the Company shall in good faith cooperate so as not to jeopardize resolution of either issue. In the event of any conference
with any taxing authority as to the Excise Tax or associated income taxes, the Grantee shall permit the representative of the Company
to accompany the Grantee, and the Grantee and his representative shall cooperate with the Company and its representative.

 

(g)              
The Company shall be responsible for all charges of the Accountants.

 

(h)              
The Company and the Grantee shall promptly deliver to each other copies of any written communications, and summaries of any verbal
communications, with any taxing authority regarding the Excise Tax covered by this Exhibit B.

 

(i)                
Nothing in this Exhibit B is intended to violate the Sarbanes-Oxley Act of 2002 and to the extent that any advance or repayment
obligation hereunder would do so, such obligation shall be modified so as to make the advance a nonrefundable payment to the Grantee and
the repayment obligation null and void.

 

    B-2

     

    

 

(j)                
Notwithstanding the foregoing, any payment or reimbursement made pursuant to this Exhibit B shall be paid to the Grantee
promptly and in no event later than the end of the calendar year next following the calendar year in which the related tax is paid by
the Grantee or where no taxes are required to be remitted, the end of the Grantee’s calendar year following the Grantee’s
calendar year in which the audit is completed or there is a final and nonappealable settlement or other resolution of the litigation.

 

(k)              
The provisions of this Exhibit B shall survive the termination of the Grantee’s employment with the Company for any
reason and the termination of the Award Agreement.

 

    B-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]